Edition:
India

Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

19.38USD
15 Jun 2018
Change (% chg)

-- (--)
Prev Close
$19.38
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
439,322
52-wk High
$25.92
52-wk Low
$10.40

Select another date:

Wed, May 9 2018

BRIEF-Corcept Therapeutics Reports Qtrly Revenue $57.7 Million

* CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-Corcept Therapeutics Files Lawsuit Against Teva Pharmaceuticals For Infringement Of Korlym Patents

* CORCEPT THERAPEUTICS FILES LAWSUIT AGAINST TEVA PHARMACEUTICALS FOR INFRINGEMENT OF KORLYM PATENTS

BRIEF-Corcept Therapeutics Q4 GAAP Earnings Per Share $0.77

* CORCEPT THERAPEUTICS ANNOUNCES 2017 FINANCIAL RESULTS AND POSITIVE INTERIM RESULTS OF RELACORILANT PHASE 2 TRIAL

BRIEF-Corcept Therapeutics Q4 GAAP Earnings Per Share $0.77

* CORCEPT THERAPEUTICS ANNOUNCES 2017 FINANCIAL RESULTS AND POSITIVE INTERIM RESULTS OF RELACORILANT PHASE 2 TRIAL

BRIEF-Corcept Therapeutics Receives Letter on saying Teva Pharmaceuticals USA Submitted An Abbreviated New Drug Application

* CORCEPT THERAPEUTICS - RECEIVED PARAGRAPH IV NOTICE LETTER ADVISING THAT TEVA PHARMACEUTICALS USA SUBMITTED AN ABBREVIATED NEW DRUG APPLICATION TO FDA

BRIEF-Corcept Therapeutics, Dohmen Entered Into Settlement Agreement And Mutual Release Of Any And All Claims That May Have Existed Between Parties

* CORCEPT THERAPEUTICS - CO, DOHMEN ENTERED INTO SETTLEMENT AGREEMENT AND MUTUAL RELEASE OF ANY AND ALL CLAIMS THAT MAY HAVE EXISTED BETWEEN PARTIES

Select another date: